Search results

This week, ANSTO hosted the 10th annual Regional Advisory Safety Committee for research reactors in Asia pacific (RASCAP). This a joint IAEA-Asian Nuclear Safety Network (ANSN) supported forum to foster networking and regional cooperation, and for facilitating use of competencies in the region to cover specific safety issues in research reactors.

Lutetium-177 used for advanced prostate cancer

Although Australia does not use nuclear energy for power needs, it does have the nuclear capabilities, knowledge, and expertise provided by ANSTO to ensure the national interest in nuclear matters is protected and advanced.

Read about an ANSTO scientist and their work to prepare for a school project or interview.

ANSTO manufacture and supply a range of radiopharmaceuticals, radiochemicals, kits and accessories for use in research, industry and the health sector.

ANSTO has safely managed its radioactive waste for over 60 years. Waste is managed in accordance with national and international standards.

Thirty years of ANSTO's unique capability in monitoring fine particle pollution provides insight on bushfire smoke.

Nuclear engineer, Robert Mardus-Hall, with his research partner Andrew Pastrello, are developing nuclear power based solutions for space missions to the Moon and Mars.

Scandium 47, a therapeutic radioisotope and potential theranostic, has been produced for the first time at ANSTO. Theranostics are used to both diagnose and treat disease.